Literature DB >> 28286449

Treatment of Recurrent Clostridium difficile Diarrhea.

Elizabeth S Huebner1, Christina M Surawicz1.   

Abstract

Treatment of recurrent Clostridium difficile-associated diarrhea can be challenging. Once patients develop recurrent disease, further episodes are common and can continue for months or even a year or more. Treatment begins with a repeat standard 10-day course of antibiotics, followed by tapering and/or pulsing of the antibiotic dose. Probiotics can also be useful, particularly the nonpathogenic yeast Saccharomyces boulardii. Stool reconstitution via fecal enemas, colonoscopy, and nasogastric tubes have been performed to restore normal colonic flora. Additional approaches under investigation, such as vaccination against C. difficile, show encouraging preliminary results.

Entities:  

Keywords:  Lactobacillus GG; Recurrent Clostridium difficile–associated disease; Saccharomyces boulardii; metronidazole; vancomycin

Year:  2006        PMID: 28286449      PMCID: PMC5335640     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  61 in total

1.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis.

Authors:  C A Liacouras; D A Piccoli
Journal:  J Clin Gastroenterol       Date:  1996-04       Impact factor: 3.062

3.  Risk factors for early recurrent Clostridium difficile-associated diarrhea.

Authors:  A N Do; S K Fridkin; A Yechouron; S N Banerjee; G E Killgore; A M Bourgault; M Jolivet; W R Jarvis
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

4.  Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.

Authors:  D Seal; S P Borriello; F Barclay; A Welch; M Piper; M Bonnycastle
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

Review 5.  Treatment of Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

6.  Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

Authors:  Jaap T van Dissel; Nanda de Groot; Charles Mh Hensgens; Sandra Numan; Ed J Kuijper; Peter Veldkamp; Jan van 't Wout
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

7.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces.

Authors:  A Schwan; S Sjölin; U Trottestam; B Aronsson
Journal:  Scand J Infect Dis       Date:  1984

9.  Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.

Authors:  Marlene Wullt; Marie-Louise Johansson Hagslätt; Inga Odenholt
Journal:  Scand J Infect Dis       Date:  2003

10.  Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.

Authors:  T A Bowden; A R Mansberger; L E Lykins
Journal:  Am Surg       Date:  1981-04       Impact factor: 0.688

View more
  5 in total

Review 1.  Fecal microbiota transplantation for the management of Clostridium difficile infection.

Authors:  Krishna Rao; Vincent B Young
Journal:  Infect Dis Clin North Am       Date:  2015-03       Impact factor: 5.982

Review 2.  Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.

Authors:  Elizabeth Ann Misch; Nasia Safdar
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

Review 3.  Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection.

Authors:  Raghavendra Paknikar; Joel Pekow
Journal:  Surg Infect (Larchmt)       Date:  2018-10-09       Impact factor: 2.150

Review 4.  Therapeutic faecal microbiota transplantation: current status and future developments.

Authors:  Thomas J Borody; Lawrence J Brandt; Sudarshan Paramsothy
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

5.  Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Authors:  Zeid Karadsheh; Sachin Sule
Journal:  N Am J Med Sci       Date:  2013-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.